The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-((2-(3,5-dimorpholinophenylamino)pyrimidin-4-yl)(methyl)amino)-4-methylphenyl)methanol ID: ALA1762530
PubChem CID: 24894017
Max Phase: Preclinical
Molecular Formula: C27H34N6O3
Molecular Weight: 490.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1
Standard InChI: InChI=1S/C27H34N6O3/c1-20-3-4-21(19-34)15-25(20)31(2)26-5-6-28-27(30-26)29-22-16-23(32-7-11-35-12-8-32)18-24(17-22)33-9-13-36-14-10-33/h3-6,15-18,34H,7-14,19H2,1-2H3,(H,28,29,30)
Standard InChI Key: BUHNODQEWUMKMH-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
18.4849 -13.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4838 -14.0982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1983 -14.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9146 -14.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9118 -13.2675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1965 -12.8585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6295 -14.5090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1940 -12.0337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9091 -11.6199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9086 -10.7988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1948 -10.3846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4800 -10.7979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4789 -11.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7692 -14.5101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0527 -14.0943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3403 -14.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3354 -15.3277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0491 -15.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7678 -15.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3432 -14.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0546 -14.5072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7679 -14.0944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7670 -13.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0470 -12.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3369 -13.2729 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0428 -12.0329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7550 -11.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1798 -10.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7497 -10.7962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4568 -10.3817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1836 -11.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4742 -12.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3265 -11.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4786 -12.8491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4490 -9.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1594 -9.1379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
4 5 1 0
7 20 1 0
2 3 1 0
20 21 2 0
5 6 2 0
21 22 1 0
6 1 1 0
22 23 2 0
8 13 1 0
23 24 1 0
9 10 1 0
24 25 2 0
25 20 1 0
10 11 1 0
24 26 1 0
11 12 1 0
26 27 1 0
27 32 2 0
12 13 1 0
31 28 2 0
28 30 1 0
29 27 1 0
29 30 2 0
1 2 2 0
2 14 1 0
31 32 1 0
14 15 1 0
4 7 1 0
3 4 2 0
26 33 1 0
6 8 1 0
32 34 1 0
8 9 1 0
30 35 1 0
35 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 490.61Molecular Weight (Monoisotopic): 490.2692AlogP: 3.46#Rotatable Bonds: 7Polar Surface Area: 86.22Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.66CX Basic pKa: 4.53CX LogP: 3.95CX LogD: 3.95Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.52Np Likeness Score: -1.06
References 1. Barlaam B, Ducray R, Lambert-van der Brempt C, Plé P, Bardelle C, Brooks N, Coleman T, Cross D, Kettle JG, Read J.. (2011) Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series., 21 (8): [PMID:21441027 ] [10.1016/j.bmcl.2011.03.009 ] 2. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361 ]